ASH 2020: Results of a study examining R-CHOP chemoimmunotherapy combined with avelumab for first line treatment of DLBCL.
Home / Resource Library / Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study